Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: An observational study

Journal of Clinical Oncology

Volumn 31, Issue 32, 2013, Pages 4046-4053

  Klein Hesselink, Esther N ^a   Klein Hesselink, Mariëlle S ^a   De Bock, Geertruida H ^a   Gansevoort, Ron T ^a   Bakker, Stephan J L ^a   Vredeveld, Eline J ^a   Van Der Horst Schrivers, Anouk N A ^a   Van Der Horst, Iwan C C ^a   Kamphuisen, Pieter W ^a   Plukker, John T M ^a   Links, Thera P ^a   Lefrandt, Joop D ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADULT; AGED; CANCER PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROTROPIN BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; THYROID TUMOR;

CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; THYROTROPIN;

EID: 84891719299     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.49.1043     Document Type: Conference Paper

References (28)

1. Bray F, Ren JS, Masuyer E, et al: Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 132:1133-1145, 2013
2. Schlumberger MJ: Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306, 1998
3. Pujol P, Daures JP, Nsakala N, et al: Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 81:4318-4323, 1996
4. Biondi B, Cooper DS: Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid 20:135-146, 2010
5. Sugitani I, Fujimoto Y: Does postoperative thyrotropin suppression therapy truly decrease recurrence in papillary thyroid carcinoma? A randomized controlled trial. J Clin Endocrinol Metab 95: 4576-4583, 2010
6. Abonowara A, Quraishi A, Sapp JL, et al: Prevalence of atrial fibrillation in patients taking TSH suppression therapy for management of thyroid cancer. Clin Invest Med 35:E152-E156, 2012
7. Abdulrahman RM, Delgado V, Hoftijzer HC, et al: Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma. Thyroid 21:471-476, 2011
8. Smit JW, Eustatia-Rutten CF, Corssmit EP, et al: Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: A randomized, placebo-controlled study. J Clin Endocrinol Metab 90:6041-6047, 2005
9. Shargorodsky M, Serov S, Gavish D, et al: Long-term thyrotropin-suppressive therapy with levothyroxine impairs small and large artery elasticity and increases left ventricular mass in patients with thyroid carcinoma. Thyroid 16:381-386, 2006
10. Horne MK 3rd, Singh KK, Rosenfeld KG, et al: Is thyroid hormone suppression therapy prothrombotic? J Clin Endocrinol Metab 89:4469-4473, 2004
11. Parle JV, Maisonneuve P, Sheppard MC, et al: Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: A 10-year cohort study. Lancet 358:861-865, 2001
12. Biondi B: How could we improve the increased cardiovascular mortality in patients with overt and subclinical hyperthyroidism? Eur J Endocrinol 167:295-299, 2012
13. Eustatia-Rutten CF, Corssmit EP, Biermasz NR, et al: Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab 91:313-319, 2006
14. Links TP, van Tol KM, Jager PL, et al: Life expectancy in differentiated thyroid cancer: A novel approach to survival analysis. Endocr Relat Cancer 12:273-280, 2005
15. Akslen LA, Haldorsen T, Thoresen SO, et al: Survival and causes of death in thyroid cancer: A population-based study of 2479 cases from Norway. Cancer Res 51:1234-1241, 1991
16. Pacini F, Schlumberger M, Dralle H, et al: European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803, 2006
17. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al: Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214, 2009
18. Jonklaas J, Sarlis NJ, Litofsky D, et al: Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 16: 1229-1242, 2006
19. Lambers Heerspink HJ, Brantsma AH, de Zeeuw D, et al: Albuminuria assessed from firstmorning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol 168:897-905, 2008
20. Brierley JD, Panzarella T, Tsang RW, et al: A comparison of different staging systems predictability of patient outcome: Thyroid carcinoma as an example. Cancer 79:2414-2423, 1997
21. Sobin LH, Fleming ID (eds): TNM Classification of Malignant Tumours (ed 5). New York, NY, Wiley-Liss, 1997
22. Sobin LH, Fleming ID (eds): TNM Classification of Malignant Tumours (ed 6). New York, NY, Wiley-Liss, 2002
23. van Tol KM, Jager PL, de Vries EG, et al: Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin. Eur J Endocrinol 148:589-596, 2003
24. Comprehensive Cancer Centre the Netherlands: Oncoline: Cancer Clinical Practice Guidelines. http://www.oncoline.nl/index.php?language-en
25. van Dijk D, Plukker JT, van der Horst-Schrivers AN, et al: The value of detectable thyroglobulin in patients with differentiated thyroid cancer after initial 131-I therapy. Clin Endocrinol 74:104-110, 2011
26. Carlin JB, Li N, Greenwood P, et al: Tools for analyzing multiple imputed datasets. Stata J 3:1-20, 2003
27. Yang L, Shen W, Sakamoto N: Populationbased study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer. J Clin Oncol 31:468-474, 2013
28. Darby SC, Ewertz M, McGale P, et al: Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368:987-998, 2013